Sign in Create account

Hemo Organic Limited

Services · Commercial Services & Supplies

BSE: 524590
₹21.88
▲ 1.04 (4.99%)
Sept. 28, 2026 · BSE · bse_bhavcopy
Quality
14/100
Weak
Valuation
—/100
Expensive
Momentum
94/100
Bullish

QVM read Momentum-led Quality Weak, Valuation Expensive, Momentum Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹8 Cr
PE (TTM)
Data unavailable.
Price to Book
57.1
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
85.3
Free Cash Flow
₹-1 Cr
as of March 31, 2026
Industry median ₹-0 Cr (372 companies)
EPS Growth (YoY)
16.00%
as of June 30, 2026
Industry median 0.00% (300 companies)
Net Profit Growth (TTM)
-96.14%
as of June 30, 2026
Industry median 0.00% (325 companies)
Operating Revenue Growth (TTM)
37.74%
as of June 30, 2026
Industry median 0.00% (317 companies)
Profit Growth (YoY)
-22.83%
as of Dec. 31, 2025
Industry median 2.13% (293 companies)
Revenue Growth (YoY)
-61.60%
as of March 31, 2026
Industry median 7.61% (227 companies)
Current Ratio
2.81
as of March 31, 2026
Industry median 2.48 (345 companies)
Debt to Equity
32.37
as of March 31, 2026
Industry median 0.06 (315 companies)
Interest Coverage
-1.65
as of Sept. 30, 2025
Industry median 2.71 (293 companies)
Net Margin
-54.58%
as of March 31, 2026
Industry median 3.80% (247 companies)
Operating Margin (EBIT)
-32.04%
as of March 31, 2026
Industry median 6.24% (257 companies)
Operating Margin (TTM)
-13.61%
as of June 30, 2026
Industry median 4.63% (310 companies)
Return on Assets
-19.46%
as of March 31, 2026
Industry median 0.99% (329 companies)
Return on Capital Employed
-17.36%
as of March 31, 2026
Industry median 2.68% (300 companies)
Return on Equity
-653.12%
as of March 31, 2026
Industry median 2.11% (328 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 5 met
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (32.37)
  • No Return on equity is 15% or more (-653.1%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • Yes 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

4 of 5 met
  • No Valuation score is Undervalued (70 or more)
  • Yes Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • Yes Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
5.0%
Low 21.8600 · High 21.8800
1W return
5.0%
Low 21.8600 · High 21.8800
1M return
15.7%
Low 17.9700 · High 21.8800
52W return
70.3%
Low 17.9700 · High 21.8800
Lifetime High ₹138.1500 (June 25, 2012)
Lifetime Low ₹4.1700 (Nov. 26, 2013)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish6
Bearish0
5D
20.2
10D
18.3
20D
15.8
50D
13.1
100D
11.6
200D
9.6

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

21.87
Pivot
First resistance21.89
Second resistance21.89
Third resistance21.91
First support21.87
Second support21.85
Third support21.85
Day RSI82.1
Day MFI26.0
Day MACD2.66
Day MACD signal1.76

Beta

1M—
3M—
1Y—
3Y0.44

Price change analysis

↑ 15.7%
Over 1 Month
LowHigh
17.9721.88
↑ 70.3%
Over 3 Months
LowHigh
17.9721.88
↑ 70.3%
Over 6 Months
LowHigh
17.9721.88
↑ 70.3%
Over 1 Year
LowHigh
17.9721.88
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹— Cr
Net profit (June 30, 2026)
₹-0 Cr
Basic EPS (June 30, 2026)
₹-0.2100

Ranks #256 of 315 in Commercial Services & Supplies by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter16.85%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 16.85% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 281 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
7 Sep 2026 RAJYGURU JAYDIP GIRISHBHAI Bulk Sell 17,751 17.9700 BSE
7 Sep 2026 NILESH CHAVDA Bulk Sell 17,767 17.9700 BSE
7 Sep 2026 JASANI DHARMENDRA BHAI BECHARBHAI Bulk Buy 111,341 18.2500 BSE
20 Jul 2026 AYUSH DHARMENDRABHAI JASANI Bulk Sell 5,713 24.4200 BSE
20 Jul 2026 AVINASHSINGHBIRENDRASINGHRAJPUT Bulk Sell 23,000 24.4200 BSE
20 Jul 2026 AYUSH DHARMENDRABHAI JASANI Bulk Buy 40,318 24.3400 BSE
13 Jul 2026 AYUSH DHARMENDRABHAI JASANI Bulk Sell 2,980 23.2500 BSE
13 Jul 2026 AYUSH DHARMENDRABHAI JASANI Bulk Buy 30,403 23.2600 BSE
29 Jun 2026 AYUSH DHARMENDRABHAI JASANI Bulk Buy 54,669 20.1200 BSE
29 May 2026 PRADIP BHARATBHAI DAVE Bulk Buy 18,169 18.6700 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from DINESH ALLORGA LTD. to Hemo Organic Limited

All corporate actions →

Corporate Announcements

All 19 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
3 Oct 2026 Board Meeting Hemo Organic Ltd - 524590 - Board Meeting Outcome for Outcome Of Board Meeting
3 Oct 2026 Company Update Hemo Organic Ltd - 524590 - Appointment of Company Secretary and Compliance Officer
29 Sep 2026 Board Meeting Hemo Organic Ltd - 524590 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday, 3Rd October, 2026.
28 Sep 2026 Insider Trading / SAST Hemo Organic Ltd - 524590 - Closure of Trading Window
25 Sep 2026 Others Hemo Organic Ltd - 524590 - Board Meeting Outcome for The Meeting To Be Held Today I.E., Friday, 25Th September, 2026
25 Sep 2026 Insider Trading / SAST Hemo Organic Ltd - 524590 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
25 Sep 2026 Insider Trading / SAST Hemo Organic Ltd - 524590 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
25 Sep 2026 Insider Trading / SAST Hemo Organic Ltd - 524590 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
25 Sep 2026 Company Update Hemo Organic Ltd - 524590 - Announcement under Regulation 30 (LODR)-Allotment
21 Sep 2026 Company Update Hemo Organic Ltd - 524590 - Cancellation of Board Meeting

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Healthy liquidity (Current Ratio 2.81)

Weaknesses

  • Low Return on Equity (-653.1%)
  • Thin net profit margin (-54.6%)
  • High financial leverage (Debt/Equity 32.37)
  • Declining revenue YoY (-61.6%)
  • Declining profit YoY (-22.8%)

Opportunities

Data unavailable.

Threats

  • RSI in overbought territory (82.1)
  • Weak interest coverage (-1.7x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Hemo Organic Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.